Pharma Core
Trademark details
Pharma Core® is a registered trademark used for Chemicals For Use In the Manufacture of Pharmaceuticals, Drugs Discovered Through Biotechnology, Biochemicals and Agrochemicals Chemical Synthesis Services, Namely, Custom Synthesis of Chemicals For Others and owned by Pharmacore, Inc.. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Chemicals For Use In the Manufacture of Pharmaceuticals, Drugs Discovered Through Biotechnology, Biochemicals and Agrochemicals Chemical Synthesis Services, Namely, Custom Synthesis of Chemicals For Others |
| Serial Number: | 76382666 |
| Registration Number: | 2785534 |
| Filing Date: | Mar 18, 2002 |
|
Last Applicant(s)/ Owner(s) of Record | Pharmacore, Inc.4170 Mendenhall Oaks Parkway, Suite 110 |
| Related Products: | Chemicals, Material Treatment |
Web Sites
powered by 
Total : 6,840,000 View more »
CorePharma : Focused on developing, manufacturing and marketing ...
Our Products CorePharma develops, manufactures and markets high-quality, targeted generic and branded prescription pharmaceuticals.
Pharmaceutical Core Salaries in Middlesex, NJ | Simply Hired
Compare Pharmaceutical Core salaries. Free Pharmaceutical Core salary information at SimplyHired.com.
Core Gestra Pvt. Ltd.- Best Pharmaceutical Company in India| Core ...
Core Group is one of the reputed and most trusted company, which is involved in research and marketing of active pharmaceutical ingredients.
What are pharma's core competencies? | InPharm
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.
News and Blogs
Total : 2 View more »
H&R Wasag's Q1 EBITDA up 10% on sales volumes-31/05/2007-ICIS News
...at €207.3m. "The main driver of growth was the continuation of the favourable trend in the chemical-pharmaceutical core business, which generated 87% of consolidated revenue in the first quarter," the company said. "The...
H&R Wasag sells explosives division-26/04/2007-ICIS News
...this disposal represents an important step forward in our drive to concentrate on our high-growth chemical-pharmaceutical core business,” said Horst Hollstein, chief executive of H&R Wasag. He added that the specialty chemicals...
Explore Related Topics:
